uPA binding increases UPAR localization to lipid rafts and modifies the receptor microdomain composition

Biochimica et Biophysica Acta - Biomembranes

Volumn 1778, Issue 1, 2008, Pages 250-259

  Sahores, Macarena ^a,b,c   Prinetti, Alessandro ^d   Chiabrando, Gustavo ^c   Blasi, Francesco ^a,b   Sonnino, Sandro ^d  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^c UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Immunoprecipitation; Lipid raft; Urokinase; Urokinase receptor

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LIPID; METHYL BETA CYCLODEXTRIN; MITOGEN ACTIVATED PROTEIN KINASE; UROKINASE RECEPTOR;

ARTICLE; CELL CULTURE; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOLYSIS; HUMAN; HUMAN CELL; LIPID MEMBRANE; PRIORITY JOURNAL;

CATALYSIS; CELL LINE; CHOLESTEROL; DETERGENTS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; IMMUNOPRECIPITATION; LIPIDS; MEMBRANE MICRODOMAINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; SPHINGOLIPIDS; SULFUR RADIOISOTOPES; TRITIUM; URINARY PLASMINOGEN ACTIVATOR;

EID: 38349018479     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2007.09.030     Document Type: Article

References (44)

1. Svennerholm L. Ganglioside designation. Adv. Exp. Med. Biol. 125 (1980) 11
2. IUPAC-IUBMB & Nomenclature, J.C.o.B. Pure Appl. Chem. 69 (1997) 2475-2487
3. IUPAC-IUBMB & Nomenclature, J.C.o.B. Carbohydr. Res. 312 (1998) 167-175
4. Ploug M., Ronne E., Behrendt N., Jensen A.L., Blasi F., and Dano K. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. J. Biol. Chem. 266 (1991) 1926-1933
5. Blasi F., and Carmeliet P. uPAR: a versatile signalling orchestrator. Nat. Rev., Mol. Cell Biol. 3 (2002) 932-943
6. Cunningham O., Andolfo A., Santovito M.L., Iuzzolino L., Blasi F., and Sidenius N. Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions. EMBO J. 22 (2003) 5994-6003
7. Stahl A., and Mueller B.M. The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae. J. Cell Biol. 129 (1995) 335-344
8. Brown D.A., and Rose J.K. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68 (1992) 533-544
9. van Meer G., and Simons K. Lipid polarity and sorting in epithelial cells. J. Cell. Biochem. 36 (1988) 51-58
10. Hakomori S., Handa K., Iwabuchi K., Yamamura S., and Prinetti A. New insights in glycosphingolipid function: "glycosignaling domain," a cell surface assembly of glycosphingolipids with signal transducer molecules, involved in cell adhesion coupled with signaling. Glycobiology 8 (1998) xi-xix
11. Prinetti A., Iwabuchi K., and Hakomori S. Glycosphingolipid-enriched signaling domain in mouse neuroblastoma Neuro2a cells. Mechanism of ganglioside-dependent neuritogenesis. J. Biol. Chem. 274 (1999) 20916-20924
12. Prinetti A., Chigorno V., Tettamanti G., and Sonnino S. Sphingolipid-enriched membrane domains from rat cerebellar granule cells differentiated in culture. A compositional study. J. Biol. Chem. 275 (2000) 11658-11665
13. Alonso M.A., and Millan J. The role of lipid rafts in signalling and membrane trafficking in T lymphocytes. J. Cell Sci. 114 (2001) 3957-3965
14. Zajchowski L.D., and Robbins S.M. Lipid rafts and little caves. Compartmentalized signalling in membrane microdomains. Eur. J. Biochem. 269 (2002) 737-752
15. Simons K., and Toomre D. Lipid rafts and signal transduction. Nat. Rev., Mol. Cell Biol. 1 (2000) 31-39
16. Lucero H.A., and Robbins P.W. Lipid rafts-protein association and the regulation of protein activity. Arch. Biochem. Biophys. 426 (2004) 208-224
17. Prinetti A., Chigorno V., Prioni S., Loberto N., Marano N., Tettamanti G., and Sonnino S. Changes in the lipid turnover, composition, and organization, as sphingolipid-enriched membrane domains, in rat cerebellar granule cells developing in vitro. J. Biol. Chem. 276 (2001) 21136-21145
18. Prinetti A., Prioni S., Chigorno V., Karagogeos D., Tettamanti G., and Sonnino S. Immunoseparation of sphingolipid-enriched membrane domains enriched in Src family protein tyrosine kinases and in the neuronal adhesion molecule TAG-1 by anti-GD3 ganglioside monoclonal antibody. J. Neurochem. 78 (2001) 1162-1167
19. Wei Y., Yang X., Liu Q., Wilkins J.A., and Chapman H.A. A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling. J. Cell Biol. 144 (1999) 1285-1294
20. Wei Y., Waltz D.A., Rao N., Drummond R.J., Rosenberg S., and Chapman H.A. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol. Chem. 269 (1994) 32380-32388
21. Wei Y., Lukashev M., Simon D.I., Bodary S.C., Rosenberg S., Doyle M.V., and Chapman H.A. Regulation of integrin function by the urokinase receptor. Science 273 (1996) 1551-1555
22. Resnati M., Pallavicini I., Wang J.M., Oppenheim J., Serhan C.N., Romano M., and Blasi F. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 1359-1364
23. Liu D., Aguirre Ghiso J., Estrada Y., and Ossowski L. EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. Cancer Cell 1 (2002) 445-457
24. Nykjaer A., Petersen C.M., Moller B., Jensen P.H., Moestrup S.K., Holtet T.L., Etzerodt M., Thogersen H.C., Munch M., Andreasen P.A., et al. Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. J. Biol. Chem. 267 (1992) 14543-14546
25. Sabharanjak S., and Mayor S. Folate receptor endocytosis and trafficking. Adv. Drug Deliv. Rev. 56 (2004) 1099-1109
26. Riboni L., Bassi R., Sonnino S., and Tettamanti G. Formation of free sphingosine and ceramide from exogenous ganglioside GM1 by cerebellar granule cells in culture. FEBS Lett. 300 (1992) 188-192
27. Vainio S., Heino S., Mansson J.E., Fredman P., Kuismanen E., Vaarala O., and Ikonen E. Dynamic association of human insulin receptor with lipid rafts in cells lacking caveolae. EMBO Rep. 3 (2002) 95-100
28. Rybin V.O., Xu X., Lisanti M.P., and Steinberg S.F. Differential targeting of beta -adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway. J. Biol. Chem. 275 (2000) 41447-41457
29. Gomez-Mouton C., Abad J.L., Mira E., Lacalle R.A., Gallardo E., Jimenez-Baranda S., Illa I., Bernad A., Manes S., and Martinez A.C. Segregation of leading-edge and uropod components into specific lipid rafts during T cell polarization. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 9642-9647
30. Hakomori S. Glycosylation defining cancer malignancy: new wine in an old bottle. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 10231-10233
31. Manfredi M.G., Lim S., Claffey K.P., and Seyfried T.N. Gangliosides influence angiogenesis in an experimental mouse brain tumor. Cancer Res. 59 (1999) 5392-5397
32. Ono M., Handa K., Withers D.A., and Hakomori S. Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation. Cancer Res. 59 (1999) 2335-2339
33. Zurita A.R., Maccioni H.J., and Daniotti J.L. Modulation of epidermal growth factor receptor phosphorylation by endogenously expressed gangliosides. Biochem. J. 355 (2001) 465-472
34. Crespo P.M., Zurita A.R., and Daniotti J.L. Effect of gangliosides on the distribution of a glycosylphosphatidylinositol-anchored protein in plasma membrane from Chinese hamster ovary-K1 cells. J. Biol. Chem. 277 (2002) 44731-44739
35. Miljan E.A., and Bremer E.G. Regulation of growth factor receptors by gangliosides. Sci. STKE 2002 (2002) RE15
36. Miljan E.A., Meuillet E.J., Mania-Farnell B., George D., Yamamoto H., Simon H.G., and Bremer E.G. Interaction of the extracellular domain of the epidermal growth factor receptor with gangliosides. J. Biol. Chem. 277 (2002) 10108-10113
37. Guerrero J., Santibanez J.F., Gonzalez A., and Martinez J. EGF receptor transactivation by urokinase receptor stimulus through a mechanism involving Src and matrix metalloproteinases. Exp. Cell Res. 292 (2004) 201-208
38. Grassme H., Jendrossek V., Bock J., Riehle A., and Gulbins E. Ceramide-rich membrane rafts mediate CD40 clustering. J. Immunol. 168 (2002) 298-307
39. Gulbins E., and Kolesnick R. Raft ceramide in molecular medicine. Oncogene 22 (2003) 7070-7077
40. Carter H.E., Rothfus J.A., and Gigg R. Biochemistry of the sphingolipids: XII. conversion of cerebrosides to ceramides and sphingosine; structure of Gaucher cerebroside. J. Lipid Res. 2 (1961) 228-234
41. Toyokuni T., Nisar M., Dean B., and Hakomori S. A facile and regiospecific titration of sphingosine: synthesis of (2S,3R,4E)-2-amino-4-octadene-1,3-diol-1-3H. J. Labelled Compd Radiopharm. 29 (1991) 567-574
42. Tettamanti G., Bonali F., Marchesini S., and Zambotti V. A new procedure for the extraction, purification and fractionation of brain gangliosides. Biochim. Biophys. Acta 296 (1973) 160-170
43. Chigorno V., Riva C., Valsecchi M., Nicolini M., Brocca P., and Sonnino S. Metabolic processing of gangliosides by human fibroblasts in culture-formation and recycling of separate pools of sphingosine. Eur. J. Biochem. 250 (1997) 661-669
44. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275